O'Neil Global Advisors, Inc. Vertex Pharmaceuticals Inc Transaction History

O'Neil Global Advisors, Inc.

  • $392 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 15, 2022
SELL
$273.83 - $305.53 $2.9 Million - $3.24 Million
-10,602 Reduced 83.47%
2,100 $608,000
Q2 2022

Sep 12, 2022
BUY
$234.96 - $292.55 $188,437 - $234,625
802 Added 6.74%
12,702 $3.58 Million
Q1 2022

May 12, 2022
BUY
$221.42 - $260.97 $2.63 Million - $3.11 Million
11,900 New
11,900 $3.11 Million

Others Institutions Holding VRTX

# of Institutions
1,724
Shares Held
222M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $119B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track O'Neil Global Advisors, Inc. Portfolio

Follow O'Neil Global Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Neil Global Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on O'Neil Global Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email